China Aoxing Pharmaceutical Company has elected Mr Jiaqi Wang to its Board of Directors. Mr Wang replaces Mr Zhongshun Qiao, who resigned from the Board because of personal reasons.
Mr Wang is the Founder and President of Hebei Jinzita Investment Company, an investment firm focusing on corporate finance, mergers & acquisitions in China. Mr Wang spent most of his career in Bank of China (BOC). From 1984 to 2004, Mr Wang handled several important positions at BOC. He also spent three years at the Hong Kong office of the BOC overseeing currency trade, international finance and accounting transactions of the audit department. During his 20-year tenure at the BOC, he was in charge of many investment projects across various industry sectors and gained extensive experience in directing strategic planning, business execution and risk management for Chinese corporations.
Mr Wang has earned a Bachelor of Arts degree in Finance from the Hebei University of Economics and Business and an associate degree in international finance from the Bank of China Community College. He has also received an auditing certificate from the Bank of China and a mid-level certificate in accounting from the London Chamber of Commerce and Industry (LCCI).
Mr Zhenjiang Yue, China Aoxing's Chairman and CEO, said, “We are pleased to have Mr. Wang join our Board. He brings extensive experience in corporate management, finance and accounting which will be extremely beneficial to our company as we assess strategic issues and capitalize on opportunities to broaden our presence for high value pain management products in China.”